echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > More than 1.35 billion people are covered by basic medical insurance nationwide

    More than 1.35 billion people are covered by basic medical insurance nationwide

    • Last Update: 2020-01-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    China has built the largest basic medical security system in the world in 20 years Cross province direct medical settlement, centralized drug purchase, medical insurance catalog adjustment The medical insurance system has become increasingly sound, the people's demand for medical services has been greatly released, the burden of people's medical care has been substantially reduced, and the health level of the whole people has been significantly improved It took only 20 years for China to build the largest basic medical security system in the world More than 1.3 billion Chinese people can afford to see and use medicine Patients with serious and chronic diseases have new drugs and special drugs Poor patients are subsidized to participate in insurance The number of people who become poor due to illness and return to poverty is reduced to more than 1 million China has created today's miracle by giving full play to its institutional advantages Our country insists on taking people's health as the center, and a higher quality and more reliable national medical security system is being improved Ms Zhang, a 52 year old insured resident of Hebei Province who covers the whole people and has established the world's largest basic medical insurance system, has been hospitalized in Beijing Union Medical College Hospital for 24 times since January 2018, spending 247500 yuan in total, of which 175600 yuan was paid by medical insurance, accounting for 70.95% of the reimbursement As early as 2017, Hebei and Beijing have been connected to the National Remote Medical settlement platform On this basis, Beijing, Tianjin and Hebei have signed a cooperative agreement on coordinated development of medical security Hebei will include 3 Tianjin and 15 high-quality medical institutions in Beijing into the designated medical insurance institutions, with the same standard and treatment as the inpatients in the province After the signing of the agreement, the local government soon opened a direct settlement with Beijing In July 2019, it also opened an online filing, making it more convenient for residents like Ms Zhang to see a doctor for reimbursement On the one hand, the reimbursement ratio has been improved Before the signing of the agreement, Ms Zhang's medical expenses were settled 21 times, accounting for 70.22%; after the signing of the agreement, they were settled three times, accounting for 79.83% On the other hand, reimbursement is more convenient, and it is put on the official account of WeChat After seeing the disease, it is not necessary to reimburse the receipt of the documents, and do not need to run errands, advance funds, wait for reimbursement, and settle the bill directly when discharging "For people like me who need to see doctors frequently, health insurance is like an umbrella, and it rains in time I like health insurance." Zhang said Ms Zhang's experience is the true portrayal of the development of medical insurance in China, from self-care to universal medical insurance, from running errands to advance funds to direct settlement According to the statistics of the National Health Insurance Bureau, at present, the number of people participating in basic medical insurance in China exceeds 1.35 billion, and the insured rate is about 97% 28000 designated medical institutions across the country have realized direct settlement of cross provincial and non local medical treatment, including more than 85% of the three-level designated hospitals, more than 50% of the two-level designated hospitals and more than 10% of the grass-roots designated hospitals Across the country, 4.246 million person times of cross provincial and non local medical treatment have been settled directly, and 59.97 billion yuan has been paid by medical insurance fund 80% of the poor people in rural areas have been reimbursed for filing cards The number of people who are poor due to illness and returning to poverty has decreased from 28.5 million in 2014 to more than 1 million In recent years, medical insurance has made use of information and intelligent means to facilitate the participation of insurance workers and residents in the insurance, payment and settlement For example, many places have been registered by mobile phone APP and WeChat official account, and have been insured and paid by mobile payment means The constantly optimized public management services of medical insurance, together with more and more solid security capabilities, improve people's experience, enhance people's satisfaction, and enhance the sense of reform Zheng Gongcheng, Professor of Renmin University of China and President of China social security society, said that at present, China has built the world's largest medical security system, benefiting the Chinese people, who account for about 19% of the global population, and creating a miracle of medical insurance reform and development in the history of human development The health insurance system is becoming more and more perfect, the people's demand for medical services is greatly released, the burden of people's medical treatment continues to be greatly reduced, the health level of the whole people is significantly improved, the life expectancy per capita is increased to 77 years old, and the main health indicators of residents are generally better than the average level of middle and high-income countries "Group purchase" drugs, many of the commonly used drugs have been greatly reduced Ms Jiang, 57, a resident of Shanghai, has suffered from chronic hepatitis B for nearly 20 years and has been taking lamivudine tablets At the beginning of 2019, due to the drug resistance to lamivudine, doctors suggested that Ms Jiang take entecavir dispersible tablets, trade name Runzhong, with the price of 311.87 yuan per box Due to the high price, the cost of this medicine has become a big burden for Ms Jiang But to Ms Jiang's surprise, when she bought medicine in the hospital on March 22, 2019, she found that Runzhong reduced its price by only 17.36 yuan, more than 90% lower than before It turns out that the state has organized centralized purchase of the drug, and the drug price has been significantly reduced Ms Jiang immediately felt that the burden was lighter and her confidence in fighting chronic hepatitis was greatly enhanced In fact, it is not only entecavir dispersible tablets that have been greatly reduced in price, but also montmorillonite powder, cefuroxime axetil, and irbesartan, which are used to treat diarrhea Since 2019, the drugs commonly used by the common people have been purchased in a centralized way through national organizations, with an average price reduction of more than half The pilot of centralized drug purchase and use organized by the state is also known as the "4 + 7" pilot By the end of 2018, China has piloted 25 kinds of drugs in 11 cities At the end of September 2019, the pilot expanded to the whole country, and the average price of drugs purchased in two centralized volumes fell by more than 50%, 25% lower than the average price of "4 + 7" pilot, and it is estimated that the drug cost will be saved by 25.3 billion yuan nationwide Shanghai is one of the "4 + 7" pilot areas for centralized procurement and use of drugs organized by the state Since 2015, it has explored the procurement and use of some drugs in three batches and gained rich experience For example, a near-infrared spectrum tracking and monitoring mechanism has been established to "batch check" the winning products supplied to Shanghai market to ensure the quality; the distribution enterprises must cover all administrative regions of the city, respond to the orders within 12 hours, and deliver them in place within 24 hours to ensure the supply; the medical institutions purchase the selected drugs and the non selected drugs with an automatic 1:1 ratio limit to ensure the selected products Always greater than 50%, make sure to use etc From March 20, 2019, the pilot procurement of "4 + 7" was implemented By the end of December of that year, the total procurement amount of the 25 pilot varieties of medical institutions in Shanghai was 576 million (pieces / grains / pieces), and the total procurement amount was 804 million yuan, better than expected Recently, 33 varieties of drugs have been targeted for centralized purchase by the second batch of national organizations The results of the selection will be announced recently, and more patients will benefit from it From 11 cities to all provinces in China, an additional 33 varieties were added on the basis of 25 varieties The state organized the centralized purchase of drugs to reduce the price of more and more commonly used drugs and constantly reduce the burden of medical treatment for the masses Wu Ming, assistant director of Peking University's medical department, said that the centralized procurement of drugs organized by the state has achieved remarkable results and is in the right direction First of all, on the premise of ensuring the quality of drugs, carrying out volume procurement has greatly reduced the price and benefited the common people Secondly, the centralized procurement with volume has changed the competition mode of the pharmaceutical industry: before, there were irregular or even illegal practices in the competition of the pharmaceutical industry, which destroyed the market rules, and the enterprises lacked the innovation power Volume purchase ensures the sales volume of the enterprise The enterprise can focus on improving product quality, enterprise efficiency and R & D innovation At the same time, it guides doctors to use drugs reasonably, creates conditions for promoting the reform of payment mode, establishing the mechanism of cost control and adjusting the price of medical services, and forces the hospital to change its development mode Wu Ming said: "this is a strategic measure to purify the pharmaceutical circulation environment, improve the industry ecology, construct a market order of fair competition, and promote the innovation of the pharmaceutical industry It is a breakthrough to strengthen the promotion of" three medical linkage " It has not only practical significance, but also far-reaching historical significance " Ms Ma is a non-small cell lung adenocarcinoma patient from Gansu Province In 2019, she stopped taking Iressa and began to use enrotinib instead Ms Ma bought a box of medicine at 3409 yuan The medical insurance reimbursed 63% of the medicine and the individual paid more than 1000 yuan After taking the medicine, she felt good about herself Her lymph nodes were smaller and there was no pain Enrotinib is one of the 17 anticancer drugs that entered the medical insurance through negotiation in 2018, with a price reduction rate of 45% In 2018, a total of 17 anticancer drugs successfully entered the medical insurance through special negotiations, with an average price reduction of 56.7% The number of lung cancer cases in China is the most, and the majority of them are non-small cell lung cancer There are a lot of lung cancer drugs that are included in the medical insurance with the price reduction of androtinib, benefiting a large number of patients Anticancer drugs have high unit price and large dosage, especially the newly listed patent innovative drugs, which are often "sky high" However, these patent innovative drugs with special effects have good clinical treatment effect Even if the price is high, they will be sought after by patients all over the world These anticancer drugs enter the medical insurance through special negotiation, the price is greatly reduced, greatly reducing the burden of patients, more patients can afford to use them In addition to anticancer drugs, in the new round of medical insurance catalog adjustment in 2019, in the regular access stage, 148 varieties of national basic drugs, chronic diseases, rare diseases, children's drugs, etc have entered the medical insurance, with more comprehensive varieties 154 varieties with obvious abuse and low value were transferred out of the catalogue In the negotiation access stage, some patent exclusive drugs with high clinical value, but high price or great influence on the fund, such as PD-1 monoclonal antibody immune drugs, Sumeria, propionoxate and other world-famous tumor and hepatitis C latest special drugs, have a total of 70 kinds, which have been reduced to "civilian price" through negotiation and entered the medical insurance at the lowest price in the world, with an average decrease of 60.7% The structure optimized catalogue is more practical, more supportable and more suitable for people's drug demand It is estimated that after some negotiated drugs are included in the reimbursement, the personal burden of patients will be reduced to less than 20% of the original, and that of individual drugs to less than 5% Ding Jinxi, a professor at China Pharmaceutical University, said that medical insurance has a strong "group purchase" advantage It can buy different drugs with different purchase methods, which can greatly improve the use efficiency of medical insurance funds and meet people's demand for good drugs As for which medicine to choose, we should make a comprehensive evaluation of the efficacy, price and cost-effectiveness of the medicine Those drugs that are not expensive and easy to use are often the first choice At the same time, we need to measure the level of medical insurance payment to ensure that medical insurance can be affordable and affordable There are many good medicines and varieties, and the medical insurance catalogue is "unforgettable" This is the powerful function of national health insurance as a "super buyer" and the institutional advantage of giving full play to Chinese characteristics In the future, it will continue to upgrade and improve to benefit all the people "Through scientific top-level design and efficient action plan, we will speed up the establishment of a multi-level medical security system covering the whole people, urban and rural areas as a whole, with clear rights and responsibilities, moderate security and sustainability, so as to provide more reliable medical security for all the people." Zheng Gongcheng said (reporter Li Hongmei, Shen shaotie) Mengmeng
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.